Clinical Trial Update: Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma [NA]

View source ↗

Summary

Clinical trial update comparing two carboplatin dosing levels in groups C and D for intraocular retinoblastoma. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Intraocular Retinoblastoma | NA | Status: UNKNOWN